InChI=1S/C40H64O8/c1-7-9-11-13-15-17-19-21-32(42)47-36-28(4)39(46)30(24-29(26-41)25-38(45)31(39)23-27(3)35(38)44)34-37(5,6)40(34,36)48-33(43)22-20-18-16-14-12-10-8-2/h23-24,28,30-31,34,36,41,45-46H,7-22,25-26H2,1-6H3/t28-,30+,31-,34-,36-,38+,39-,40-/m1/s1 |
DGOSGFYDFDYMCW-OEFRVDPMSA-N |
C=1[C@]2([C@]3([C@@]([C@H](OC(=O)CCCCCCCCC)[C@H]([C@@]2([C@]4([C@](C(=O)C(=C4)C)(CC1CO)O)[H])O)C)(C3(C)C)OC(=O)CCCCCCCCC)[H])[H] |
|
TRPV4 agonist
An agonist at the transient receptor potential vanilloid 4 (TRPV4).
|
|
View more via ChEBI Ontology
(1aR,1bS,4aS,7aS,7bS,8R,9R,9aS)-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulene-9,9a-diyl didecanoate
|
12,13-didecanoyl-4α-phorbol
|
ChEBI
|
4alpha-phorbol 12,13-didecanoate
|
ChEBI
|
4alphaPDD
|
SUBMITTER
|
2514323
|
Reaxys Registry Number
|
Reaxys
|
27536-56-7
|
CAS Registry Number
|
ChemIDplus
|
12243861
|
PubMed citation
|
Europe PMC
|
12729936
|
PubMed citation
|
Europe PMC
|
15126053
|
PubMed citation
|
Europe PMC
|
16439673
|
PubMed citation
|
Europe PMC
|
16675722
|
PubMed citation
|
Europe PMC
|
16954339
|
PubMed citation
|
Europe PMC
|
17071727
|
PubMed citation
|
Europe PMC
|
17124270
|
PubMed citation
|
Europe PMC
|
17184838
|
PubMed citation
|
Europe PMC
|
17636010
|
PubMed citation
|
Europe PMC
|
18064606
|
PubMed citation
|
Europe PMC
|
18206306
|
PubMed citation
|
Europe PMC
|
18458941
|
PubMed citation
|
Europe PMC
|
18826956
|
PubMed citation
|
Europe PMC
|
18845910
|
PubMed citation
|
Europe PMC
|
18945825
|
PubMed citation
|
Europe PMC
|
19017361
|
PubMed citation
|
Europe PMC
|
19033444
|
PubMed citation
|
Europe PMC
|
19701771
|
PubMed citation
|
Europe PMC
|
19759329
|
PubMed citation
|
Europe PMC
|
19879881
|
PubMed citation
|
Europe PMC
|
19948193
|
PubMed citation
|
Europe PMC
|
20363225
|
PubMed citation
|
Europe PMC
|
|